HomeCTOR • NASDAQ
add
Citius Oncology Inc
Previous close
$0.89
Day range
$0.88 - $0.92
Year range
$0.55 - $49.00
Market cap
64.32M USD
Avg Volume
104.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.47M | 59.25% |
Net income | -7.74M | -59.97% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -3.54% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 112.00 | — |
Total assets | 91.44M | 86.97% |
Total liabilities | 55.80M | 92.00% |
Total equity | 35.64M | — |
Shares outstanding | 71.55M | — |
Price to book | 1.77 | — |
Return on assets | -20.53% | — |
Return on capital | -44.19% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.74M | -59.97% |
Cash from operations | 0.00 | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | 2.80M | 59.25% |
About
Founded
2021
Website
